Bone mineral density in patients with rheumatoid arthritis treated with infliximab

Antzeko izenburuak

• Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice
  nork: Neven, N, et al.
  Argitaratua: (2005)
• Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density
  nork: Lodder, M, et al.
  Argitaratua: (2004)
• Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis
  nork: Vis, M, et al.
  Argitaratua: (2006)
• Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis
  nork: Wolbink, G, et al.
  Argitaratua: (2005)
• Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis
  nork: Güler‐Yüksel, M, et al.
  Argitaratua: (2007)